22 November 2025 in La Presse Médicale
SRSivatharshini Ramalingam
4 May 2022 in Arquivos Brasileiros de Cardiologia
Caso clínico Paciente do sexo masculino, 72 anos, com história pregressa de hipertensão arterial, diabetes não insulino-dependente, tabagismo ativo e angina crônica estável (angiocoronariografia mostrou estenose grave em ramo marginal obtuso de pequeno porte). Apresentava também história de etilismo, calcificação pancreática e litíase renal, sem história de Câncer, Sepse ou Tuberculose que justificassem essas calcificações difusas. Apresentou-se no ambulatório de cardiologia com queixa de angina e dispneia classe II da New York Heart Association (NYHA). O eletrocardiograma (ECG) mostrava ritmo [...] Caso clínico Paciente do sexo masculino, 72 anos, com história pregressa de hipertensão arterial, diabetes não insulino-dependente, tabagismo ativo e angina crônica estável (angiocoronariografia mostrou estenose grave em ramo marginal obtuso de pequeno porte). Apresentava também história de etilismo, calcificação pancreática e litíase renal, sem história de Câncer, Sepse ou Tuberculose que justificassem essas calcificações difusas. Apresentou-se no ambulatório de cardiologia com queixa de angina e dispneia classe II da New York Heart Association (NYHA). O eletrocardiograma (ECG) mostrava ritmo
2 September 2026 in European Heart Journal Open
Aims: Cardio-oncology has emerged as a rapidly growing discipline of cardiology. Despite its clinical relevance, structured education remains limited across medical curricula. The Cardio-Oncologists Of tomorrow Leaders (COOL) group of the European Society of Cardiology (ESC) Council of Cardio-Oncology conducted an international survey to assess the current state of cardio-oncology training opportunities and perceived needs among healthcare professionals. Methods and results: An anonymized, web-based survey was distributed to cardiologists, cardiology residents and other healthcare professionals treating patients with cancer. A total of 398 respondents completed this survey (mean age 44 ± 12 years; 60% female; 73% board-certified cardiologists). Only 10% reported exposure to cardio-oncology during medical school, and 17% during residency. The majority (>70%) indicated no structured cardio-oncology training opportunities at their institution, with national cardio-oncology programmes available to only 19% of them. Respondents identified the ESC and national cardiac societies (72%) as main stakeholders responsible for developing educational initiatives. Most participants preferred fellowships at centres of excellence (56%), webinars (53%) and university certifications (51%) as learning formats. A strong consensus (over 85%) emerged that all general cardiologists should be familiar with key cardio-oncology principles, including diagnosis and risk-stratification of cardiotoxicity. Responses differed across respondents’ training status, work setting (academic vs. non-academic) and country. Conclusion: In parallel with the general growth of the field, there is increasing need of structured and harmonized training in cardio-oncology, including during medical education. Interpretation of results is however, limited by possible selection bias and the absence of a defined denominator, which precluded calculation of response rate.